CytomX Therapeutics (CTMX) Payables: 2014-2025
Historic Payables for CytomX Therapeutics (CTMX) over the last 10 years, with Sep 2025 value amounting to $646,000.
- CytomX Therapeutics' Payables fell 54.57% to $646,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year decrease of 58.99%. This contributed to the annual value of $1.1 million for FY2024, which is 25.38% down from last year.
- According to the latest figures from Q3 2025, CytomX Therapeutics' Payables is $646,000, which was up 184.58% from $227,000 recorded in Q2 2025.
- CytomX Therapeutics' 5-year Payables high stood at $5.2 million for Q3 2022, and its period low was $227,000 during Q2 2025.
- In the last 3 years, CytomX Therapeutics' Payables had a median value of $1.1 million in 2024 and averaged $1.1 million.
- In the last 5 years, CytomX Therapeutics' Payables skyrocketed by 241.42% in 2022 and then slumped by 85.95% in 2025.
- CytomX Therapeutics' Payables (Quarterly) stood at $2.8 million in 2021, then dropped by 0.32% to $2.8 million in 2022, then tumbled by 48.10% to $1.5 million in 2023, then fell by 25.38% to $1.1 million in 2024, then slumped by 54.57% to $646,000 in 2025.
- Its Payables stands at $646,000 for Q3 2025, versus $227,000 for Q2 2025 and $276,000 for Q1 2025.